ºÚÁϳԹÏÍø

Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • ºÚÁϳԹÏÍø News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Thursday, Jul 9 2020

Full Issue

Research Roundup: Research Papers; Obesity; Brain Damage; ALS; Vaping; HPV

Each week, KHN compiles a selection of recently released health policy studies and briefs.

The coronavirus pandemic has posed a special challenge for scientists: Figuring out how to make sense of a flood of scientific papers from labs and scientists unfamiliar to them. More than 6,000 coronavirus-related preprints from researchers around the world have been posted since the pandemic began, without the usual peer review as a quality check. Some are poor quality, while others, including papers from China from early in the course of the epidemic, contain vital information. The beauty of science is the facts are supposed to speak for themselves. (Harris, 7/7)

As Covid-19 has shuttered schools across the globe, leaving parents to pick up childcare responsibilities, a handful of studies have converged on the same grim picture: Women in academic science and medicine are publishing far less since the pandemic hit. Two studies published in May looked at preprint servers and found that women in life and medical sciences aren’t seeing the same gains in publishing compared to their male peers since the pandemic started. (Isselbacher, 7/9)

A retrospective cohort study of 1,687 COVID-19 patients at two New York City hospitals published yesterday in the Annals of Internal Medicine revealed that 31% were obese, and obese patients were at higher risk of respiratory failure. Researchers at Weill Cornell Medicine studied the electronic medical record data of adults hospitalized with the novel coronavirus from Mar 3 to May 15 for outpatient body mass index (BMI) measurements recorded within 3 months after hospitalization. They defined obesity as a BMI of 30 or higher, and 31.1% of patients fit that category, with 5.4% of all patients being morbidly obese. (7/7)

The same process that causes dew drops to form on a blade of grass appears to play an important role in Alzheimer's and other brain diseases. The process, known as phase transition, is what allows water vapor to condense into liquid water, or even freeze into solid ice. That same sort of process allows brain cells to constantly reorganize their inner machinery. (Hamilton, 7/8)

Diagnosis of EVALI (electronic cigarette, or vaping, product use–associated lung injury) should be suspected on the basis of vaping history and clinical presentation. Glucocorticoid treatment led to an improvement in symptoms and lung function. The 6-minute walk test may help determine oxygen needs at discharge.

Multilevel interventions that include provider education, data feedback, tailored systems changes, and early initiation of the human papillomavirus vaccine series may improve vaccine series initiation and completion beyond the conclusion of the intervention period. (Perkins et al, 7/1)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Today, April 22
  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • ºÚÁϳԹÏÍø
  • Republish Our Content
  • Contact Us

Follow Us

  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF